Bortenat Injection (bortezomib) is a drug used to treat specific forms of cancer as of my most recent update in September 2021. It is mainly used to treat multiple myeloma and mantle cell lymphoma and is a member of the medication class known as proteasome inhibitors. Bortenat slows or stops the course of cancer by preventing the growth and division of cancer cells. The injection is typically given by a medical expert and is an essential component of the treatment plan for people with these particular cancer types. Bortenat should only be used under professional medical supervision because it has the potential for negative effects like any other medicine does. Consult a healthcare professional for the most up-to-date information.
1. Proteasome Inhibitor: Bortenat is a member of the medication class known as proteasome inhibitors. These substances target and inhibit the proteasomes found in cancer cells, which results in cell death and slows tumour growth.
2. Compared to conventional chemotherapy, Bortenat selectively targets cancer cells while sparing certain healthy cells, which may lessen some side effects.
3. Intravenous Administration: To ensure accurate dosing and monitoring, healthcare providers often inject bortenat intravenously (IV).
1. Multiple myeloma is a kind of cancer that affects plasma cells in the bone marrow. Bortenat is a crucial part of the treatment for multiple myeloma.
2. Mantle Cell Lymphoma: Mantle cell lymphoma is a form of non-Hodgkin lymphoma, and it is also treated with bortenat.
3. Prolonged Survival: In patients with multiple myeloma and mantle cell lymphoma, Bortenat has been proven to improve overall survival and progression-free survival.
4. Bortenat has the potential to be used in combination with other anti-cancer drugs to increase the effectiveness of treatment.
Individual responses to treatment may differ from person to person, thus any side effects should be explored with a healthcare professional. Consult a healthcare provider or refer to up-to-date medical sources for the most recent information on Bortenat Injection.
1. Plasma cells in the bone marrow are affected by the cancer multiple myeloma, which is typically treated with bortenat. Both freshly diagnosed cases and relapsed/refractory ones utilise it.
2. Mantle Cell Lymphoma: Bortenat is also used to treat this non-Hodgkin lymphoma, known medically as mantle cell lymphoma.
Bortenat may have a number of adverse effects, which might differ in frequency and severity from person to person.
1. Irritation and Vomiting
2. Nausea or indigestion
4. Low blood cell counts (low white blood cells, low platelets, and anaemia)
5. Peripheral neuropathy, which causes pain, tingling, or numbness in the hands and feet
7. Skin Reactions or Rash
8. Blood pressure is low
Serious side effects include blood clotting abnormalities, heart or lung troubles, and liver or kidney problems can manifest. Additionally, the immune system may be suppressed by bortenat, raising the risk of infections. It's critical to notify a healthcare professional as soon as you experience any unexpected symptoms or side effects. This list is not all-inclusive, so people should speak with their doctor or review current medical literature for a thorough understanding of possible side effects and drug interactions.